Glucosamine for Cardiovascular mortality (observational) and Glucosamine
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
Glucosamine for Cardiovascular mortality (observational)
Evidence grade C — Association only
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
Glucosamine
A joint mainstay with genuinely divided evidence — modest benefit at best, and a surprising cardiovascular-mortality observational signal in its favor.
Grade C2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Glucosamine for Cardiovascular mortality (observational) | Glucosamine |
|---|---|---|
| Cardiovascular mortality (observational) | Evidence grade CUnclear effectmixedAssociation only | Evidence grade CUnclear effectmixedAssociation only |
Graded only in Glucosamine for Cardiovascular mortality (observational)
None — every outcome it grades is graded in both.
Graded only in Glucosamine
- Osteoarthritis pain Small effectEvidence grade C
Conditions
Only in Glucosamine for Cardiovascular mortality (observational)
None.
Only in Glucosamine
- Osteoarthritis May improveEvidence grade C
What each entry says about the other
- Glucosamine for Cardiovascular mortality (observational)’s entry · Goes with: Read the full Glucosamine monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.